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The proteolytic generation of mature interleukin-l/l (IL-la) from its inactive precursor does not proceed by a convention- 
al pathway for hormonal processing. Pro-IL-ID is found dispersed in the cytoplasm, and there are no basic amino acid 
residues or other commonly recognized processing sites adjoining the mature N-terminus. Processing appears to occur 
during release of the hormone. In the present study, we have identified a specific protease that generates mature IL-lb 
from the precursor. This enzyme is co-induced with the hormone, and it differs in its cleavage specificity and inhibitor 
sensitivity from all known proteases. 
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1. INTRODUCTION 
Interleukin-lfl is a key hormone of the immune 
system, with roles in hematopoiesis, inflammation 
and wound healing [l]. Mature IL-lfl consists of 
the C-terminal 153 residues of an inactive 33 kDa 
precursor, which is produced primarily by macro- 
phages [2]. The maturation and release of this hor- 
mone do not proceed by conventional mechanisms. 
Unlike the case with most secretory proteins, the 
precursor lacks a signal sequence [2] and is not 
associated with membrane-bound compartments 
[3]. No mature IL-l,8 is found in the cytoplasm 
[4,5], suggesting that processing occurs during or 
following release of the precursor. Further indica- 
tions of an ,unusual maturation pathway are the 
absence of any typical processing sites near the 
mature N-terminus (-Tyr-Val-His-Asp precedes the 
N-terminal Ala-Pro-) [2] and the inability of 
fibroblasts to process the prohormone [6]. Pulse- 
chase studies indicate that mature IL-l,8 is 
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generated by a single cleavage of the precursor ([5], 
our unpublished results), although a 26 kDa form 
has also been observed [6]. The monocytic cell line 
THP-1 can be induced to produce the mature hor- 
mone [7]. Here, we used THP-1 cells to investigate 
whether there is a specific protease that generates 
mature IL-l,& from the precursor. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
THP-1 cells were obtained from the American Type Culture 
Collection. The cells were propagated and stimulated (with lipo- 
polysaccharide, hydroxyurea, and silica) as described by Op- 
penheim [7] for 16 h or for shorter lengths of time as indicated. 
2.2. Cell iysates 
Cells were harvested by centrifugation at 2000 x g for 5 min. 
and then washed once by resuspension in Hank’s balanced salt 
solution and recentrifugation. The cells were then resuspended 
to 1 x lO’/ml in a solution of 10 mM Tris-HCl (pH 8.1), 5 mM 
dithiothreitol, frozen on dry ice, and thawed in a 37°C water 
bath. For the experiment shown in fig.1, the lysis buffer also 
contained 1 mM PMSF, 1 pg/ml leupeptin, and 1 Fg/ml 
pepstatin. 
2.3. Protease assay, inhibitor study, N-terminal sequencing, 
and bioassay 
These procedures were carried out as previously described 
WI. 
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2.4. Purification 
Lysates were freeze-thawed four times and then centrifuged 
for 20 min at 36 590 x g. This procedure released over 50% of 
the processing activity to the supernatant fraction. The 
solubilized activity was applied to a column of DEAE-Sephacel 
equilibrated with 10 mM Tris-HCl (pH 8.1), 5 mM dithio- 
threitol. It was eluted with 80-140 mM NaCl. (Fractions were 
desalted by centrifugation through Biogel PdDG prior to assay, 
because as little as 50 mM NaCl was found to inhibit the pro- 
tease.) The eluted material was diluted 1: 5 with 10 mM Tris- 
HCl (pH 8.1), 5 mM dithiothreitol and then applied to a column 
of procion red agarose (Bethesda Research Laboratories). The 
activity was eluted with 0.5-0.8 M NaCl, concentrated 20-fold 
in a Centriprep-10 concentrator, and then subjected to gel filtra- 
tion with Sephadex G-75. 
2.5. Peptide analysis 
The peptide synthesis and analysis of cleavage products were 
carried out as in [9], except hat the digestions were terminated 
by freezing rather than by addition of trichloroacetic acid. 
3. RESULTS 
3.1. Generation of mature IL-l@ by THP-I lysates 
Lysates of THP-1 cells were incubated with 
recombinant pro-IL-lfl, and processed forms of 
the protein were then detected by Western blot 
analysis with a C-terminus-specific antibody [S]. 
We found that lysates of unstimulated cells con- 
verted little if any pro-IL-l,8 to the 17.5 kDa 
mature form of the hormone (fig. 1, 0 h, + ), but a 
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lysate of cells that had been stimulated to produce 
IL-l,8 clearly generated a fragment that co- 
migrated with the mature hormone (fig. 1, 6 h, + ). 
This product was purified [lo], and its N-terminal 
15 amino acids were sequenced and found to be 
identical to the corresponding residues of mature 
IL-l,8 [2]. The purified product was also found to 
have the level of biological activity expected for the 
corresponding amount of authentic IL-1,8. 
3.2. Co-induction of the processing activity and 
IL-l/3 
We then determined whether the expression of 
the induced proteolytic activity correlated with the 
appearance of active IL-l,8 in THP-1 cultures. 
Lysates were prepared at various times following 
stimulation and tested for their ability to generate 
mature IL-l,8 from the recombinant precursor. The 
processing activity of the lysates started to in- 
crease, above a low background level, between 2 
and 3 h after stimulation (fig.1, + lanes). To 
measure the production of mature IL-1B by the 
cultures, aliquots of the culture medium were 
withdrawn at various times and assayed for IL-l 
activity (little IL-la is produced by THP-1 cells 
[7]). We found a large increase in the level of active 
IL-l during the same interval in which the process- 
ing activity began to rise: there was no activity at 1 
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Fig.1. Western blot analysis showing time course of expression of mature-IL-l&generating activity. THP-1 cells were lysed at the in- 
dicated number of hours following stimulation, and the lysates were prepared immediately for Western blot analysis (- ) or first in- 
cubated for 40 min with recombinant prorIL-l,f? (+). (PRO.) PRO-IL-lfl incubated with lysis buffer, (MAT.) mature IL-l,f?, (MW) 
molecular mass standards - 14.3, 18.4, and 25.7 kDa. The immunoreactive proteins of less than 33 kDa in the pro-IL-b3 preparation 
were generated uring fermentation, and we have been unable to separate them from the full-length precursor [8]. In addition to en- 
dogenous pro-IL-la, the various stained bands in the lysates themselves may be due to fragments of the precursor generated uring cell 
lysis or to nonspecific staining of highly abundant proteins. 
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Fig.2. Inhibitor sensitivity of mature-IL-l&generating activity 
in lysates. (1) No inhibitor, (2) 1 mM PMSF, (3) 1 &ml pep- 
statin, (4) 2 mM EDTA, (5) 0.1 mM E-64, (6) 1 mM iodoacetate. 
Aliquots of a lysate of THP-1 cells were incubated with IO mM 
Tris-HCl buffer (pH 8.1) or with the inhibitors for 10 min prior 
to the incubation with pro-IL-b9 and subsequent Western blot 
analysis. (PRO) pro-IL-la, (LYS) unincubated lysate without 
added pro-IL-lfl or any inhibitors, (MAT) mature IL-la. The 
small amount of mature IL-la in the unincubated lysate was 
generated from endogenous pro-IL-lb during the preparation 
of the lysate. The E-64 solution did inhibit papain (not shown). 
h, 261 + 62 U/ml at 2 h, and 3020 + 140 U/ml at 
3 h. 
3.3. Inhibitor sensitivity of the crude processing 
activity 
To determine whether the induced proteolytic 
activity could be due to a single protease, an 
B 
inhibitor-sensitivity study was carried out. We 
found that one inhibitor, iodoacetate, completely 
inhibited the activity, while PMSF, pepstatin, 
EDTA, and E-64 had little or no effect (fig.2). 
3.4. Inhibitor sensitivity and substrate specificity 
of the purified processing activity 
The activity was purified about 500-fold as 
described in section 2. This preparation converted 
virtually all of the precursor to either mature IL-lfi 
or a 26 kDa product (fig.3A). (A 26 kDa form may 
be produced by monocyte cultures as well [6] .) The 
purified protease showed the same pattern of in- 
hibitor sensitivity as had been found with the pro- 
cessing activity of the lysates (fig.3B). N- 
Ethylmaleimide was also tested (in the absence of 
dithiothreitol) and found to inhibit the enzyme 
completely (not shown). The 26 kDa product was 
subjected to N-terminal sequence analysis and 
found to result from a cleavage very similar to that 
which releases the mature hormone (see section 1): 
after Asp-27 of the precursor and preceding the se- 
quence Gly-Pro. To test further the substrate 
specificity of the enzyme, we incubated the purified 
protease with a synthetic peptide representing the 
sequence from Ala-112 to Ser-121 of pro-IL-1,8. 
Only two fragments were generated (fig.4), and 
analysis of their composition showed that they 
resulted from a single cleavage following Asp-l 16, 
the same cleavage that releases mature IL-1P from 
C 
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Fig.3. Studies with purified protease. (A) Products generated: (1) products resulting from a 60 min incubation of pro-IL-la with a con- 
centrated preparation of the purified protease, (PRO) pro-IL-l,& (MAT) mature IL-la. (B) Inhibitor sensitivity: (1) no inhibitor, (2) 1 
mM PMSF, (3) 1 pg/ml pepstatin, (4) 1 mM EDTA, (5) 0.1 mM E-64, (6) 1 mM iodoacetate. Aliquots of the purified protease prepara- 
tion were incubated with 10 mM Tris-HCl buffer (pH 8.1) or with the inhibitors for 10 min prior to the incubation with pro-IL-l@ 
(PRO) pro-IL-l@, (PREP) purified protease preparation without added pro-IL-lfl or any inhibitors, (MAT) mature IL-l,@. (C) Time 
course of reaction. The purified protease preparation was incubated with pro-IL-l/3 for the indicated number of minutes: (PRO) pro- 
IL-l/3, (PREP) purified protease preparation without added pro-IL-l,&, (MAT) mature IL-18. All samples (for A-C) were analyzed by 
Western blot. _ 
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Fig.4. Digestion of a synthetic peptide representing Ala-112 to 
Ser-121 of pro-IL-lfl (acetyl-Ala-Tyr-Val-His-Asp-Ala-Pro- 
Val-Arg-Ser-NHr). (A) Purified protease preparation. (B) Pep- 
tide mixed with the purified protease, prior to incubation. (C) 
Peptide mixed with the purified protease, after 4 h incubation at 
37°C. (D) The same as (C), except that 1 mM iodoacetate was 
added to the reaction mixture prior to incubation. Samples were 
applied to a Vydac Cts column, and material was eluted with a 
gradient of acetonitrile. Peak assignments: 2-4, impurities from 
the protease preparation; 6, peptide representing Ala-112 to 
Ser-121 of pro-IL-lb; 1, the fragment composed of Ala-117 to 
Ser-121; 5, the fragment composed of Ala-112 to Asp-116; 7, 
iodoacetate; 8, iodoacetate impurity. The amino acid analyses 
of the two generated fragments howed that they were present in 
equimolar amounts, and that the difference in peak height was 
due to a difference in extinction coefficients at 225 nm. 
the precursor. The reaction with the peptide, as 
with the precursor protein, was completely in- 
hibited by iodoacetate. As a further demonstration 
that the processing activity did not entail any in- 
termediate cleavages, the time course of the reac- 
tion with pro-IL-lfi was followed; we found that 
the two products (mature IL-1P and the 26 kDa 
form) were generated directly, without the ap- 
pearance of any intermediate forms (fig.3C). 
4. DISCUSSION 
We have found that stimulation of THP-1 cells 
to produce IL-l,& also induces the expression of a 
proteolytic activity that correctly processes pro- 
IL-l,& in vitro. Our study of this activity suggests 
that it is due to a single protease: (i) iodoacetate in- 
hibited all of the activity in cell lysates while other 
common inhibitors had no effect; (ii) the activity 
was purified 500-fold; (iii) the purified activity 
cleaved a synthetic peptide at only one site; and (iv) 
the purified preparation cleaved the precursor 
directly between Asp and Ala-Pro and between 
Asp and Gly-Pro without the prior generation of 
intermediates (our SDS-PAGE system resolves 
Asp-IL-lp from IL-l,B [9]). Our study also 
demonstrates that this enzyme has a highly 
restricted and unusual substrate specificity: (i) 
while the precursor is susceptible to cleavage at 
many points [8,9], the purified protease cleaved it 
at only these two, very similar sites; (ii) the one 
cleavage site in the synthetic peptide corresponded 
to one of the sites where the precursor was cleaved; 
and (iii) no known enzyme, other than a general 
degradative protease, perhaps, would be expected 
to effect this cleavage [I 11, and none that we have 
tested does so [8,9]. The enzyme’s sensitivity to 
iodoacetate and N-ethylmaleimide but not to the 
other class-specific inhibitors tested suggests that it 
is a cysteine protease, while its resistance to E-64 
(an inhibitor of most cysteine proteases [121) is con- 
sistent with its unusual substrate specificity. 
Evidence that this protease is required for the ac- 
tivation of the prohormone by monocytic cells in- 
cludes the correlation of its appearance with that of 
mature IL-1P following stimulation of the cells, 
and the generation of the mature hormone and a 26 
kDa form by the enzyme without intermediates, as 
appears to be the case in cultures of monocytes 
[5,6]. Our results thus indicate that the maturation 
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of IL-l@ is carried out by a specific protease, and 
that it may be possible to control IL-l@ levels by in- 
hibiting this unusual proteolytic activity. 
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